Skip to main content
. 2019 Jul 26;98(30):e16439. doi: 10.1097/MD.0000000000016439

Figure 5.

Figure 5

Forest plots and funnel plots for the risk ratio of adverse events leading to discontinuation. (A1) Forest plots for the risk ratio of adverse events leading to discontinuation (PD-1/PD-L1 + chemotherapy vs. chemotherapy). (A2) Funnel plots for the risk ratio of adverse events leading to discontinuation (PD-1/PD-L1 + chemotherapy vs. chemotherapy). (B1) Forest plots for the risk ratio of adverse events leading to discontinuation (PD-1/PD-L1 vs. chemotherapy). (B2) Funnel plots for the risk ratio of adverse events leading to discontinuation (PD-1/PD-L1 vs. chemotherapy). (C1) Forest plots for the risk ratio of adverse events leading to discontinuation (nivolumab vs. nivolumab + ipilimumab). (C2) Funnel plots for the risk ratio of adverse events leading to discontinuation (nivolumab vs. nivolumab + ipilimumab). PD-1 = programmed cell death 1, PD-L1 = programmed cell death ligand 1.